Key result
Cardiac resynchronization therapy in mildly symptomatic heart failure patients resulted in 16% worsening on the clinical composite response compared to 21% with CRT-OFF, while sustaining reverse left ventricular remodeling over 5 years.
Why the study?
Does cardiac resynchronization therapy improve reverse cardiac remodelling and reduce heart failure adverse events in patients with mild heart failure, depressed LVEF, and wide QRS complex?
Does cardiac resynchronization therapy improve reverse cardiac remodelling and reduce heart failure adverse events in patients with mild heart failure, depressed LVEF, and wide QRS complex?
Answers are grounded in this paper and cite their sources.
The 5-year follow-up of the REVERSE trial extends the evidence for the long-term benefits of CRT in patients with mild heart failure.
The role of cardiac resynchronization therapy (CRT) in patients presenting with mild manifestations of heart failure (HF), depressed left ventricular ejection fraction (LV EF), and wide QRS complex, has been addressed in four previous trials: MIRACLE ICD II,(1) MADIT-CRT,(2) RAFT,(3) and REVERSE.(4) The consistent observed benefits in reverse cardiac remodelling and reduction of heart failure adverse events have resulted in guideline recommendations for CRT in NYHA Class II patients. The guidelines also recommend further studies to determine whether survival is increased by CRT in patients with mild symptoms. The 5-year analysis of the REsynchronization reVErses Remodeling Systolic left vEntricular (REVERSE) trial, which was designed prospectively for 5-year follow-up to specifically assess the long term benefits of CRT, were recently published in the European Heart Journal.(5).
No takes yet. Share an insight, caveat, or question.
ElMaghawry et al. (2014) conducted a review in Mildly symptomatic heart failure (n=610). Cardiac resynchronization therapy (CRT ON) vs. CRT OFF (optimal medical therapy alone) was evaluated on Heart failure clinical composite response (percent worsened) (p=0.10). Cardiac resynchronization therapy in mildly symptomatic heart failure patients resulted in 16% worsening on the clinical composite response compared to 21% with CRT-OFF, while sustaining reverse left ventricular remodeling over 5 years.
Synapse has enriched 10 related papers. Consider them for comparative context: